Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice

References

• Giesy , J. P. and Kannan , K. 2002 . Perfluorochemical surfactants in the environment . Environ. Sci. Technol. , 36 ( 7 ) : 146A – 152A .
   PubMed Web of Science ®Google Scholar
• Hu , W. , Jones , P. D. , Celius , T. and Giesy , J. P. 2005 . Identification of genes responsive to PFOS using gene expression profiling . Environ. Toxicol. Pharmacol. , 19 ( 1 ) : 57 – 70 .
   PubMed Web of Science ®Google Scholar
• Giesy , J. P. and Kannan , K. 2001 . Global distribution of perfluorooctane sulfonate in wildlife . Environ. Sci. Technol. , 35 ( 7 ) : 1339 – 1342 .
   PubMed Web of Science ®Google Scholar
• Hekster , F. M. , Laane , R.W and de Voogt , P. 2003 . Environmental and toxicity effects of perfluoroalkylated substances . Rev. Environ. Contam. Toxicol. , 179 : 99 – 121 .
   PubMed Web of Science ®Google Scholar
• Houde , M. , Bujas , T. A. , Small , J. , Wells , R. S. , Fair , P. A. , Bossart , G. D. , Solomon , K. R. and Muir , D. C. 2006 . Biomagnification of perfluoroalkyl compounds in the bottlenose dolphin (Tursiops truncatus) food web . Environ. Sci. Technol. , 40 ( 13 ) : 4138 – 4144 .
   PubMed Web of Science ®Google Scholar
• Organization for Economic Co-operation and Development (OECD) . 2002 . Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts. . ENV/JM/RD , (Final).
   Google Scholar
• Andersen , M. E. , Butenhoff , J. L. , Chang , S. C. , Farrar , D. G. , Kennedy , G. L. Jr. , Lau , C. , Olsen , G. W. , Seed , J. and Wallace , K. B. 2008 . Perfluoroalkyl Acids and Related Chemistries–Toxicokinetics and Modes of Action . Toxicol. Sci. , 102 ( 1 ) : 3 – 14 .
   PubMed Web of Science ®Google Scholar
• Jensen , A. A. and Leffers , H. 2008 . Emerging endocrine disrupters: perfluoroalkylated substances . Int. J. Androl. , 31 ( 2 ) : 161 – 169 .
   PubMed Web of Science ®Google Scholar
• Lau , C. , Butenhoff , J. L. and Rogers , J. M. 2004 . The developmental toxicity of perfluoroalkyl acids and their derivatives . Toxicol. Appl. Pharmacol. , 198 ( 2 ) : 231 – 241 .
   PubMed Web of Science ®Google Scholar
• Peden-Adams , M. M. , Keller , J. M. , EuDaly , J.G. , Berger , J. , Gilkeson , G. S. and Keil , D. E. 2008 . Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate . Toxicol. Sci. , 104 ( 1 ) : 144 – 154 .
   PubMed Web of Science ®Google Scholar
• Hu , W. , Jones , P. D. , DeCoen , W. , King , L. , Fraker , P. , Newsted , J. and Giesy , J. P. 2003 . Alterations in cell membrane properties caused by perfluorinated compounds . Comp. Biochem. Physiol. C. Toxicol. Pharmacol. , 135 ( 1 ) : 77 – 88 .
   PubMed Web of Science ®Google Scholar
• Hu , W. , Jones , P. D. , Upham , B. L. , Trosko , J. E. , Lau , C. and Giesy , J. P. 2002 . Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo . Toxicol. Sci. , 68 ( 2 ) : 429 – 436 .
   PubMed Web of Science ®Google Scholar
• Guruge , K. S. , Yeung , L. W. , Yamanaka , N. , Miyazaki , S. , Lam , P. K. , Giesy , J. P. , Jones , P. D. and Yamashita , N. 2006 . Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA) . Toxicol. Sci. , 89 ( 1 ) : 93 – 107 .
   PubMed Web of Science ®Google Scholar
• Auer , C. 2000 . “ Email to OECD. Subject: Phase out of PFOS ” . In Available on USEPA Public Docket AR-226 No. 226–0629.
   Google Scholar
• Kennedy , G. L. Jr. , Butenhoff , J. L. , Olsen , G. W. , O'Connor , J.C. , Seacat , A. M. , Perkins , R. G. , Biegel , L. B. , Murphy , S. R. and Farrar , D. G. 2004 . The toxicology of perfluorooctanoate . Crit. Rev. Toxicol. , 34 ( 4 ) : 351 – 384 .
   PubMed Web of Science ®Google Scholar
• Shipley , J. M. , Hurst , C. H. , Tanaka , S. S. , DeRoos , F.L. , Butenhoff , J. L. , Seacat , A. M. and Waxman , D. J. 2004 . Trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals . Toxicol. Sci. , 80 ( 1 ) : 151 – 160 .
   PubMed Web of Science ®Google Scholar
• Taylor , B. K. , Dadia , N. , Yang , C. B. , Krishnan , S. and Badr , M. 2002 . Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia . Inflammation. , 26 ( 3 ) : 121 – 127 .
   PubMed Web of Science ®Google Scholar
• Taylor , B. K. , Kriedt , C. , Nagalingam , S. , Dadia , N. and Badr , M. 2005 . Central administration of perfluorooctanoic acid inhibits cutaneous inflammation . Inflamm. Res. , 54 ( 6 ) : 235 – 242 .
   PubMed Web of Science ®Google Scholar
• Vanden Heuvel , J.P. , Thompson , J. T. , Frame , S. R. and Gillies , P. J. 2006 . Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha . Toxicol. Sci. , 92 ( 2 ) : 476 – 489 .
   PubMed Web of Science ®Google Scholar
• Takacs , M. L. and Abbott , B. D. 2007 . Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate . Toxicol. Sci. , 95 ( 1 ) : 108 – 117 .
   PubMed Web of Science ®Google Scholar
• Chinetti , G. , Fruchart , J. C. and Staels , B. 2000 . Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation . Inflamm. Res. , 49 ( 10 ) : 497 – 505 .
   PubMed Web of Science ®Google Scholar
• Daynes , R. A. and Jones , D. C. 2002 . Emerging roles of PPARs in inflammation and immunity . Nat. Rev. Immunol. , 2 ( 10 ) : 748 – 759 .
   PubMed Web of Science ®Google Scholar
• Gelman , L. , Fruchart , J. C. and Auwerx , J. 1999 . An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer . Cell. Mol. Life Sci. , 55 ( 6–7 ) : 932 – 943 .
   PubMed Web of Science ®Google Scholar
• Hwang , D. 2000 . Fatty acids and immune responses—a new perspective in searching for clues to mechanism . Annu. Rev. Nutr. , 20 : 431 – 456 .
   PubMed Web of Science ®Google Scholar
• Dewitt , J. C. , Copeland , C. B. and Luebke , R. W. 2008 . Immune function in intact and PPARα knockout mice exposed to PFOA . Toxicologist (Supplement to Toxicol. Sci.) , 102 ( S-1 ) : 174
   Google Scholar
• Dewitt , J. C. , Copeland , C. B. , Strynar , M. J. and Luebke , R. W. 2008 . Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice . Environ Health. Perspect. , 116 ( 5 ) : 644 – 650 .
   PubMed Web of Science ®Google Scholar
• Dewitt , J. C. , Shnyra , A. , Badr , M. Z. , Loveless , S. E. , Hoban , D. , Frame , S. R. , Cunard , R. , Anderson , S. E. , Meade , B. J. , Peden-Adams , M.M. , Luebke , R. W. and Luster , M. I. 2008 . Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha . Crit. Rev. Toxicol. , 39 ( 1 ) : 76 – 94 .
   Web of Science ®Google Scholar
• Fair , P. A. , Driscoll , E. , Mollenhauer , M. A.M. , Bradshaw , S. , Yun , S. , Kannan , K. , Keil , D. E. , Bossart , G. D. and Peden-Adams. , M.M. Effects of environmentally relevant levels of perfluorooctane sulfonate (PFOS) on clinical parameters and immunological functions. . Submitted ,
   Google Scholar
• Fairley , K. J. , Purdy , R. , Kearns , S. , Anderson , S. E. and Meade , B. J. 2007 . Exposure to the Immunosuppresant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin . Toxicol. Sci. , 97 ( 2 ) : 375 – 383 .
   PubMed Web of Science ®Google Scholar
• Keil , D. E. , Mehlman , T. , Butterworth , L. and Peden-Adams , M.M. 2008 . Gestational exposure to perfluorooctane sulfonate (PFOS) suppresses immune function in B6C3F1 mice . Toxicol. Sci. , 103 ( 1 ) : 77 – 85 .
   PubMed Web of Science ®Google Scholar
• Loveless , S. E. , Hoban , D. , Sykes , G. , Frame , S. R. and Everds , N. E. 2008 . Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate . Toxicol. Sci. , 105 ( 1 ) : 86 – 96 .
   PubMed Web of Science ®Google Scholar
• Nelson , D. L. , Frazier , D. E. Jr. , Ericson , J. E. , Tarr , M. J. and Mathes , L. E. 1992 . The effects of perfluorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in Fischer 344 rats . Immunopharmacol. Immunotoxicol. , 14 ( 4 ) : 925 – 938 .
   PubMed Web of Science ®Google Scholar
• Peden-Adams , M. M. , EuDaly , J.G. , Dabra , S. , EuDaly , A. , Heesemann , L. , Smythe , J. and Keil , D. E. 2007 . Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfuramid . J. Toxicol. Environ. Health Pt. A , 70 ( 13 ) : 1130 – 1141 .
   PubMed Web of Science ®Google Scholar
• Yang , Q. , Abedi-Valugerdi , M. , Xie , Y. , Zhao , X. Y. , Moller , G. , Nelson , B. D. and DePierre , J.W. 2002 . Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid . Int. Immunopharmacol. , 2 ( 2–3 ) : 389 – 397 .
   PubMed Web of Science ®Google Scholar
• Yang , Q. , Xie , Y. , Alexson , S. E. , Nelson , B. D. and DePierre , J.W. 2002 . Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice . Biochem. Pharmacol. , 63 ( 10 ) : 1893 – 1900 .
   PubMed Web of Science ®Google Scholar
• Yang , Q. , Xie , Y. and Depierre , J. W. 2000 . Effects of peroxisome proliferators on the thymus and spleen of mice . Clin. Exp. Immunol. , 122 ( 2 ) : 219 – 226 .
   PubMed Web of Science ®Google Scholar
• Yang , Q. , Xie , Y. , Eriksson , A. M. , Nelson , B. D. and DePierre , J.W. 2001 . Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluorooctanoic acid in mice . Biochem. Pharmacol. , 62 ( 8 ) : 1133 – 1140 .
   PubMed Web of Science ®Google Scholar
• Hoff , P. T. , Van Dongen , W. , Esmans , E. L. , Blust , R. and De Coen , W.M. 2003 . Evaluation of the toxicological effects of perfluorooctane sulfonic acid in the common carp (Cyprinus carpio) . Aquat. Toxicol. , 62 ( 4 ) : 349 – 359 .
   PubMed Web of Science ®Google Scholar
• El Alwani , M. , Wu , B. X. , Obeid , L. M. and Hannun , Y. A. 2006 . Bioactive sphingolipids in the modulation of the inflammatory response . Pharmacol. Ther. , 112 ( 1 ) : 171 – 183 .
   PubMed Web of Science ®Google Scholar
• Peden-Adams , M. M. , Romano , T. A. , Rice , C. D. , EuDaly , J. , Hessemann , L. , Muir , D. C. , Houde , M. , Bossart , G. D. and Fair , P. A. Nov 14–18, 2004 . “ Immune function and clinical blood parameters correlate with perfluorinated hydrocarbon concentrations in bottlenose dolphins ” . In Abstract book , Portland , OR : Society of Environmental Toxicology and Chemistry (SETAC) North America 25th Annual Meeting .
   Google Scholar
• Peden-Adams , M. M. , Keil , D. E. , Romano , T. , Mollenhauer , M. A.M. , Fort , D. J. , Guiney , P. D. , Houde , M. , Kannan , K. , Muir , D. C. , Rice , C. D. , Stuckey , J. , Segars , A. L. , Scott , T. , Talent , L. , Bossart , G. D. , Fair , P. A. and Keller , J. M. 2009 . Health effects of perfluorinated compounds—what are the wildlife telling us? . Repro. Toxicol. , 27 ( 3–4 ) : 414 – 415 .
   Google Scholar
• Qazi , M. R. , Bogdanska , J. , Butenhoff , J. L. , Nelson , B. D. , Depierre , J. W. and Abedi-Valugerdi , M. 2007 . High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion . Toxicol. , 262 ( 3 ) : 207 – 214 .
   Web of Science ®Google Scholar
• Qazi , M. R. , Bogdanska , J. , Butenhoff , J. L. , Nelson , B. D. , DePierre , J.W. and Abedi-Valugerdi , M. Feb. 14–16, 2007 . Effect of the persistent environmental pollutants perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) on the innate immune system of mice , Arlington , VA : Society of Toxicology Contemporary Concepts in Toxicology: Perfluoroalkyl Acids and Related Chemistries- Toxicokinetics and Mode of Action Workshop .
   Google Scholar
• Houde , M. , Wells , R. S. , Fair , P. A. , Bossart , G. D. , Hohn , A. A. , Rowles , T. K. , Sweeney , J. C. , Solomon , K. R. and Muir , D. C.G. 2005 . Perfluoroalkyl compounds in free-ranging bottlenose dolphins (Tursiops truncatus) from the Gulf of Mexico and the Atlantic Ocean . Environ. Sci. Technol. , 39 : 6591 – 6598 .
   PubMed Web of Science ®Google Scholar
• Keller , J. M. , Kannan , K. , Taniyasu , S. , Yamashita , N. , Day , R. D. , Arendt , M. D. , Segars , A. L. and Kucklick , J. R. 2005 . Perfluorinated compounds in the plasma of loggerhead and Kemp's Ridley sea turtles from the Southeastern coast of the United States . Environ. Sci. Technol. , 39 ( 23 ) : 9101 – 9108 .
   PubMed Web of Science ®Google Scholar
• Olsen , G. W. , Burris , J. M. , Burlew , M. M. and Mandel , J. H. 2003 . Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations . J. Occup. Environ. Med. , 45 ( 3 ) : 260 – 270 .
   PubMed Web of Science ®Google Scholar
• Olsen , G. W. , Church , T. R. , Miller , J. P. , Burris , J. M. , Hansen , K. J. , Lundberg , J. K. , Armitage , J. B. , Herron , R. M. , Medhdizadehkashi , Z. , Nobiletti , J. B. , O'Neill , E.M. , Mandel , J. H. and Zobel , L. R. 2003 . Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors . Environ. Health Perspect. , 111 ( 16 ) : 1892 – 1901 .
   PubMed Web of Science ®Google Scholar
• House , R. V. 1999 . Theory and practice of cytokine assessment in immunotoxicology . Methods. , 19 ( 1 ) : 17 – 27 .
   PubMed Web of Science ®Google Scholar
• Hopkins , S. J. 2007 . Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration . Acta. Biomed. , 78 ( Suppl 1 ) : 231 – 247 .
   PubMedGoogle Scholar
• Jaattela , M. 1991 . Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin . Lab. Invest. , 64 ( 6 ) : 724 – 742 .
   PubMed Web of Science ®Google Scholar
• Environmental , U. S. 2000 . Protection Agency (EPA) . Health effects test guidelines. Repeated dose 28-day oral toxicity in rodents. OPPTS 870.3505, 1–9
   Google Scholar
• Luster , M. I. , Portier , C. , Pait , D. G. , White , K. L. Jr. , Gennings , C. , Munson , A. E. and Rosenthal , G. J. 1992 . Risk assessment in immunotoxicology . I: Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. , 18 : 200 – 210 .
   PubMedGoogle Scholar
• Luster , M. I. , Munson , A. E. , Thomas , P. T. , Holsapple , M. P. , Fenters , J. D. , White , K. L. Jr. , Lauer , L. D. , Germolec , D. R. , Rosenthal , G. J. and Dean , J. H. 1988 . Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice . Fundam. Appl. Toxicol. , 10 ( 1 ) : 2 – 19 .
   PubMedGoogle Scholar
• Lau , C. , Thibodeaux , J. R. , Hanson , R. G. , Rogers , J. M. , Grey , B. E. , Stanton , M. E. , Butenhoff , J. L. and Stevenson , L. A. 2003 . Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse . II: postnatal evaluation. Toxicol. Sci. , 74 ( 2 ) : 382 – 392 .
   PubMed Web of Science ®Google Scholar
• Olsen , G. W. , Burris , J. M. , Ehresman , D. J. , Froehlich , J. W. , Seacat , A. M. , Butenhoff , J. L. and Zobel , L. R. 2007 . Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers . Environ. Health Perspect. , 115 ( 9 ) : 1298 – 1305 .
   PubMed Web of Science ®Google Scholar
• Fan , H. , Zingarelli , B. , Harris , V. , Tempel , G. E. , Halushka , P. V. and Cook , J. A. 2008 . Lysophosphatidic acid inhibits bacterial endotoxin-induced pro-inflammatory response: potential anti-inflammatory signaling pathways . Mol. Med. , 14 ( 7–8 ) : 422 – 428 .
   PubMed Web of Science ®Google Scholar
• Fan , H. , Williams , D. L. , Zingarelli , B. , Breuel , K. F. , Teti , G. , Tempel , G. E. , Spicher , K. , Boulay , G. , Birnbaumer , L. , Halushka , P. V. and Cook , J. A. 2006 . Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in splenocytes by Galphai proteins . Biochim. Biophys. Acta , 1763 ( 10 ) : 1051 – 1058 .
   PubMed Web of Science ®Google Scholar
• Fan , H. , Luttrell , L. M. , Tempel , G. E. , Senn , J. J. , Halushka , P. V. and Cook , J. A. 2007 . Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression . Mol Immunol. , 44 ( 12 ) : 3092 – 3099 .
   PubMed Web of Science ®Google Scholar
• Hopkins , S. 2007 . J Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration . Acta Biomed. , 78 ( Suppl 1 ) : 231 – 247 .
   PubMedGoogle Scholar
• Wollenberg , G. K. , DeForge , L.E. , Bolgos , G. and Remick , D. G. 1993 . Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture . Am. J. Pathol. , 143 : 1121 – 1130 .
   PubMed Web of Science ®Google Scholar
• Lechner , A. J. , Velasquez , A. , Knudsen , K. R. , Johanns , C. A. , Tracy , T. F. and Matuschak , G. M. 1998 . Cholestatic liver injury increases circulating TNF-α and IL-6 and mortality after Escherichia coli endotoxin . Am. J. Respir. Crit. Care Med. , 157 : 1550 – 1558 .
   PubMed Web of Science ®Google Scholar
• Mancuso , G. , Tomasello , F. , Migliardo , M. , Delfino , D. , Cochran , J. , Cook , J. A. and Teti , G. 1994 . Benefical effects of interleukin-6 in neonatal mouse models of group B Streptococcal disease . Infect. Immun. , 62 ( 11 ) : 4997 – 5002 .
   PubMed Web of Science ®Google Scholar
• Nishimoto , N. , Ito , A. , Ono , M. , Tagoh , H. , Matsumoto , T. , Tomita , T. , Ochi , T. and Yoshizaki , K. 2000 . IL-6 inhibits the proliferation of fibroblastic synivial cells from rheumatiod arthritis patient in the presence of soluble IL-6 receptor . Inter. Immunol. , 12 ( 2 ) : 187 – 193 .
   PubMed Web of Science ®Google Scholar
• Yimin and Kohanawa , M. 2006 . A regulatory effect of the balance between TNF-α and IL-6 in the granulomatous and inflammatory response to Rhodococus aurantiacus infection in mice . J. Immunol. , 177 : 642 – 650 .
   PubMed Web of Science ®Google Scholar
• Copeland , S. , Warren , H. S. , Lowry , S. F. , Calvano , S. E. and Remick , D. 2005 . Acute inflammatory response to endotoxin in mice and humans . Clin. Diag. Lab Immunol. , 12 ( 1 ) : 60 – 67 .
   PubMedGoogle Scholar
• Clark , R. B. 2002 . The role of PPARs in inflammation and immunity . J. Leukoc. Biol. , 71 ( 3 ) : 388 – 400 .
   PubMed Web of Science ®Google Scholar
• Cuzzocrea , S. , Bruscoli , S. , Mazzon , E. , Crisafulli , C. , Donato , V. , Di Paola , R. , Velardi , E. , Esposito , E. , Nocentini , G. and Riccardi , C. 2008 . Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids . Mol. Pharmacol. , 73 ( 2 ) : 323 – 337 .
   PubMed Web of Science ®Google Scholar
• Cuzzocrea , S. , Mazzon , E. , Di Paola , R. , Peli , A. , Bonato , A. , Britti , D. , Genovese , T. , Muia , C. , Crisafulli , C. and Caputi , A. P. 2006 . The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation . J. Leukoc. Biol. , 79 ( 5 ) : 999 – 1010 .
   PubMed Web of Science ®Google Scholar
• Wolf , C. J. , Takacs , M. L. , Schmid , J. E. , Lau , C. and Abbott , B. D. 2008 . Activation of mouse and human peroxisome proliferator-activated receptor alpha (PPAR{alpha}) by perfluoroalkyl acids (PFAAs) of different functional groups and chain lengths . Toxicol. Sci. , 106 ( 1 ) : 162 – 171 .
   PubMed Web of Science ®Google Scholar
• Hill , M. R. , Clarke , S. , Rodgers , K. , Thornhill , B. , Peters , J. M. , Gonzalez , F. J. and Gimble , J. M. 1999 . Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia . Infect. Immun. , 67 ( 7 ) : 3488 – 3493 .
   PubMed Web of Science ®Google Scholar